1. Home
  2. ELUT vs GEOS Comparison

ELUT vs GEOS Comparison

Compare ELUT & GEOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELUT
  • GEOS
  • Stock Information
  • Founded
  • ELUT 2015
  • GEOS 1980
  • Country
  • ELUT United States
  • GEOS United States
  • Employees
  • ELUT N/A
  • GEOS N/A
  • Industry
  • ELUT Medical Specialities
  • GEOS Industrial Machinery/Components
  • Sector
  • ELUT Health Care
  • GEOS Industrials
  • Exchange
  • ELUT Nasdaq
  • GEOS Nasdaq
  • Market Cap
  • ELUT 79.7M
  • GEOS 72.9M
  • IPO Year
  • ELUT 2020
  • GEOS 1997
  • Fundamental
  • Price
  • ELUT $1.13
  • GEOS $18.40
  • Analyst Decision
  • ELUT Strong Buy
  • GEOS
  • Analyst Count
  • ELUT 2
  • GEOS 0
  • Target Price
  • ELUT $7.00
  • GEOS N/A
  • AVG Volume (30 Days)
  • ELUT 204.9K
  • GEOS 173.3K
  • Earning Date
  • ELUT 11-13-2025
  • GEOS 08-07-2025
  • Dividend Yield
  • ELUT N/A
  • GEOS N/A
  • EPS Growth
  • ELUT N/A
  • GEOS N/A
  • EPS
  • ELUT N/A
  • GEOS N/A
  • Revenue
  • ELUT $23,683,000.00
  • GEOS $115,527,000.00
  • Revenue This Year
  • ELUT $19.68
  • GEOS N/A
  • Revenue Next Year
  • ELUT $70.28
  • GEOS N/A
  • P/E Ratio
  • ELUT N/A
  • GEOS N/A
  • Revenue Growth
  • ELUT N/A
  • GEOS N/A
  • 52 Week Low
  • ELUT $1.14
  • GEOS $5.51
  • 52 Week High
  • ELUT $5.12
  • GEOS $21.60
  • Technical
  • Relative Strength Index (RSI)
  • ELUT 23.21
  • GEOS 56.83
  • Support Level
  • ELUT $1.17
  • GEOS $16.10
  • Resistance Level
  • ELUT $2.38
  • GEOS $17.29
  • Average True Range (ATR)
  • ELUT 0.18
  • GEOS 1.22
  • MACD
  • ELUT -0.10
  • GEOS -0.20
  • Stochastic Oscillator
  • ELUT 0.00
  • GEOS 50.58

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

About GEOS Geospace Technologies Corporation (Texas)

Geospace Technologies Corp is engaged in designing and manufacturing seismic instruments and non-seismic equipment used in the oil and gas industry. The company has three different segments: oil and gas markets, adjacent markets, and emerging markets. The oil and gas markets segment, which accounts for the majority of the company's revenue, includes traditional exploration products, wireless exploration products, and reservoir characterization products and services. The adjacent markets business is closely tied to the oil and gas markets and includes imaging products and industrial products. The company operates globally across Asia, Canada, Europe, the United States, South America, Mexico, and other regions with a majority of its revenue being generated within the United States.

Share on Social Networks: